Jakob Lauritsen (J Lauritsen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Locally Advanced

Papillary Thyroid

Top Venues

Acta oncologica (Stockholm, Sweden)

British journal of cancer

Nature reviews. Urology

Human reproduction (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

P L Jørgensen, Michael Kreiberg, Niels Jørgensen, Anders Juul, Peter Sandor Oturai, Christian Dehlendorff, Jakob Lauritsen, T Wagner, Josephine Julie Rosenvilde, Gedske Daugaard, C R Medici, Niklas Rye Jørgensen, Mikkel Bandak
Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial. Acta oncologica (Stockholm, Sweden) (2023)
Kira Bloomquist, Christina Andersen, Stine Munck, Christian Lillelund, Jakob Lauritsen
High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the Body & Cancer cohort. Acta oncologica (Stockholm, Sweden) (2023)
Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, Di Maria Jiang, Robert A Huddart, Daniel Y C Heng, Angelika Terbuch, Eric Winquist, Michal Chovanec, Marcus Hentrich, Christian Daniel Fankhauser, Jonathan Shamash, Xavier García Del Muro Solans, David Vaughn, Axel Heidenreich, Cora N Sternberg, Christopher Sweeney, Andrea Necchi, Carsten Bokemeyer, Mikkel Bandak, Abolghassem Jandari, Laurence Collette, Silke Gillessen, Joerg Beyer, Gedske Daugaard
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database. British journal of cancer (2023)
Michal Chovanec, Jakob Lauritsen, Mikkel Bandak, Christoph Oing, Gry Gundgaard Kier, Michael Kreiberg, Josephine Rosenvilde, Thomas Wagner, Carsten Bokemeyer, Gedske Daugaard
Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nature reviews. Urology 18 (4) (2021)
Laerke Priskorn, M Kreiberg, Mikkel Bandak, Jakob Lauritsen, Gedske Daugaard, J H Petersen, Lise Aksglaede, Anders Juul, Niels Jørgensen
Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy. Human reproduction (Oxford, England) 36 (9) (2021)
Sara L Garcia, Jakob Lauritsen, Zeyu Zhang, Mikkel Bandak, Marlene D Dalgaard, Rikke Linnemann Nielsen, Gedske Daugaard, Ramneek Gupta
Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients. JNCI cancer spectrum 4 (3) (2020)
Jakob Lauritsen, Mikkel Bandak, Michael Kreiberg, Julie Wang Skøtt, Thomas Wagner, Josephine Julie Rosenvilde, Lars Dysager, Mads Agerbæk, Gedske Daugaard
Long-term neurotoxicity and quality of life in testicular cancer survivors-a nationwide cohort study. Journal of cancer survivorship : research and practice 15 (4) (2020)